← Browse by Condition
Medical Condition

glioma glioblastoma multiforme

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1, Phase 2
NCT06687681 Phase 2
Recruiting

Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas

Enrollment
40 pts
Location
Iran
Sponsor
Marzieh Ebrahimi
View Trial →
NCT06810544 Phase 1, Phase 2
Recruiting

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Enrollment
191 pts
Location
United States
Sponsor
Tango Therapeutics, Inc.
View Trial →